We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
New Fortress Energy
NFE
$95.3M
| $2.42M | ﹤0.01% |
110,034
+82,034
| +293% | +$2.12M |
|
|
HAPN
1252
Happen Inc
HAPN
$2.16B
| $2.41M | ﹤0.01% |
+285,078
| New | +$2.44M |
|
1253
UFP Technologies
UFPT
$1.96B
| $2.41M | ﹤0.01% |
+9,139
| New | +$2.26M |
|
1254
Royal Bank of Canada
RY
$289B
| $2.4M | ﹤0.01% |
22,600
-152,835
| -87% | -$15.7M |
|
1255
CG Oncology
CGON
$6.12B
| $2.4M | ﹤0.01% |
+75,982
| New | +$2.63M |
|
1256
Riley Exploration Permian
REPX
$714M
| $2.4M | ﹤0.01% |
+84,651
| New | +$2.33M |
|
1257
Criteo
CRTO
$1.1B
| $2.4M | ﹤0.01% |
63,518
-61,079
| -49% | -$2.24M |
|
|
AZUL
1258
DELISTED
Azul
AZUL
| $2.39M | ﹤0.01% |
598,670
+575,344
| +2,467% | +$3.37M |
|
|
PHYT.WS
1259
CALL
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
| $2.39M | ﹤0.01% |
209,279
-9,074
| -4% | -$428 |
|
1260
Rayonier
RYN
$6.6B
| $2.39M | ﹤0.01% |
90,542
-418,861
| -82% | -$11.5M |
|
1261
AAR Corp
AIR
$5.42B
| $2.36M | ﹤0.01% |
32,471
+13,666
| +73% | +$927K |
|
1262
Zumiez
ZUMZ
$337M
| $2.35M | ﹤0.01% |
120,814
+104,514
| +641% | +$1.81M |
|
1263
Astera Labs
ALAB
$43.3B
| $2.35M | ﹤0.01% |
+38,859
| New | +$2.7M |
|
1264
Kaspi.kz JSC
KSPI
$16.6B
| $2.35M | ﹤0.01% |
18,200
-159,287
| -90% | -$19.5M |
|
1265
Adtran
ADTN
$679M
| $2.34M | ﹤0.01% |
444,198
+432,372
| +3,656% | +$2.2M |
|
1266
Celsius Holdings
CELH
$7.37B
| $2.34M | ﹤0.01% |
+40,923
| New | +$3.09M |
|
1267
Shinhan Financial Group
SHG
$32.3B
| $2.33M | ﹤0.01% |
+66,981
| New | +$2.25M |
|
1268
W.R. Berkley
WRB
$28.2B
| $2.33M | ﹤0.01% |
+44,480
| New | +$2.38M |
|
1269
Navient
NAVI
$828M
| $2.33M | ﹤0.01% |
+159,797
| New | +$2.47M |
|
1270
Amer Sports
AS
$20.5B
| $2.33M | ﹤0.01% |
185,032
-17,242
| -9% | -$253K |
|
1271
Vail Resorts
MTN
$5.63B
| $2.33M | ﹤0.01% |
+12,911
| New | +$2.57M |
|
1272
Anterix
ATEX
$1.72B
| $2.32M | ﹤0.01% |
58,652
+41,905
| +250% | +$1.36M |
|
1273
Liberty Global Class A
LBTYA
$3.54B
| $2.32M | ﹤0.01% |
+132,937
| New | +$2.25M |
|
1274
Ardagh Metal Packaging
AMBP
$2.95B
| $2.31M | ﹤0.01% |
679,889
-423,462
| -38% | -$1.59M |
|
|
INFN
1275
DELISTED
Infinera Corporation Common Stock
INFN
| $2.31M | ﹤0.01% |
378,794
-732,179
| -66% | -$3.87M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.